RA Therapeutic Peptide tetrapeptide disrupter of IgA:Alpha 1 anti-trypsin complex: Phase II Update

Peptide Therapeutics Group plc (LSE:PTD),

Read the full 55 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE